Phase 1 B-cell Non-Hodgkin Lymphoma (B-NHL) Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients

Non-Hodgkin LymphomaMantle Cell Lymphoma (MCL)CNS Lymphoma+1 more

University of Colorado, Denver68 enrolled1 locationNCT05098613

Recruiting

Phase 1Phase 2

Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma

B-cell Non-Hodgkin Lymphoma (B-NHL)

Cellectis S.A.80 enrolled10 locationsNCT05607420